3 results
Approved WMOCompleted
The primary objective of this study is:- To evaluate the effect of the elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) single-tablet regimen (STR) on renal parameters at Week 24The secondary objectives of this study are:- To…
Approved WMOCompleted
Main objective: To compare the renal elimination rate constant in CF patients receiving a daily intravenous dose of tobramycin in the morning against patients receiving a daily intravenous dose of tobramycin in the evening. Secondary objective: To…
Approved WMOCompleted
The primary objective of this study is to evaluate the feasibility of performing Superpath® in the Reinier de Graaf Hospital in Delft.